A lightweight DeepME model based on improved YOLOv11 architecture for macular edema detection and treatment monitoring - Top-Institutions - MDSpire

A lightweight DeepME model based on improved YOLOv11 architecture for macular edema detection and treatment monitoring

  • By

  • Xue Bai

  • Ming Yi

  • Tianye Chen

  • Naijing Feng

  • Quan Shi

  • Tingxue Li

  • Rui Hua

  • July 3, 2026

  • 0 min

Share

Top Institutions in Ophthalmology

Brief introduction explaining scope and methodology.

  • #1

    Department of Ophthalmology, The author’s Hospital
    Department of Ophthalmology, The author’s Hospital

    Unknown, Unknown

    Key Differentiators

    • Ophthalmology

  • #2

    Diabetic Retinopathy Clinical Research Network
    Diabetic Retinopathy Clinical Research Network

    Unknown, Unknown

    Key Differentiators

    • Ophthalmology

  • #3

    New York Eye and Ear Infirmary of Mount Sinai
    New York Eye and Ear Infirmary of Mount Sinai

    New York, NY

    Key Differentiators

    • Ophthalmology

  • #4

    Feinberg School of Medicine at Northwestern University
    Feinberg School of Medicine at Northwestern University

    Chicago, IL

    Key Differentiators

    • Ophthalmology

Original Source(s)

A lightweight DeepME model based on improved YOLOv11 architecture for macular edema detection and treatment monitoring

  • by Xue Bai, Ming Yi, Tianye Chen, Naijing Feng, Quan Shi, Tingxue Li, Rui Hua

  • July 3, 2026

Related Content

Assessing retina-specific ophthalmic counseling generated by an early public large language model across different levels of clinical urgency

Atsena Advances XLRS Gene Therapy

Atsena Therapeutics dose first patient in pivotal XLRS gene therapy trial

  • June 30, 2026

  • 2 min
Prospective randomised controlled trial to compare tissue reactions and scarring with polypropylene versus polyglactin 910 sutures in periocular skin